Boston Partners

Q1 2023 13F-HR Detailed Holdings

Location
Boston, MA
Holdings as of
3/31/2023
Date filed
5/9/2023
Form type
13F-HR
Num holdings
1,727
Total value ($000)
$72,738,020
Net value change ($000)
-1,186,171 (-1.6%)
New positions
85
Sold out positions
88
Turnover %
4.5%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AIY 463,499 255.1%
WMT 461,874 7864.4%
AJG 418,715 NEW
GOOGL 346,699 49.0%
BP 293,207 502.1%
HAL 291,622 59.7%
ARES 268,186 NEW
BMY 260,432 26.3%
CSCO 250,642 32.1%
SPG 226,437 30312.9%
Top Reduces (Value $000, Stocks/ETFs)
SCHW -779,831 -93.8%
KEY -566,225 -99.9%
COP -492,509 -59.5%
DVN -362,938 -56.2%
JNJ -348,308 -22.8%
ABBV -346,904 -42.5%
CI -332,339 -31.3%
CNC -320,218 -38.2%
UNP -298,939 -100.0%
CVS -279,658 -34.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORIX Corp Europe N.V. 028-12637
2 Robeco Institutional Asset Management B.V. 028-12635
3 Boston Partners Trust Co 028-13904
4 ORIX CORP 028-18337